https://www.selleckchem.com/Androgen-Receptor.html
Patients with κ-FLC index 100 (median value 147) at baseline had a twice as high probability for a second clinical attack within 12 months than patients with low κ-FLC index (median 28); within 24 months, the chance in patients with high κ-FLC index was 4 times as high as in patients with low κ-FLC index. The median time to second attack was 11 months in patients with high κ-FLC index whereas 36 months in those with low κ-FLC index. High κ-FLC index predicts early MS disease activity. This study provides Class II evidence that in p
Like
Comment
Share
